Business

Newborn Screening Market 2022 | Industry Share, Trends, Growth and Forecast 2027

According to the latest report by IMARC Group “Newborn Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global newborn screening market size reached US$ 880.2 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,371.7 Million by 2027, exhibiting a growth rate (CAGR) of 7.79% during 2022-2027.

Newborn screening refers to the preventive healthcare program that identifies the risk of rare and severe medical conditions in babies. It is essential to test babies at birth to determine conditions, such as physical disabilities, brain damage, and other life-threatening diseases, which can affect their normal development. Newborn screening allows early intervention, which aids in the elimination and reduction of morbidity, mortality, and disability in affected newborns.

Request for a free sample copy of this report: https://www.imarcgroup.com/newborn-screening-market/requestsample

Market Trends:

The global newborn screening market is primarily driven by the growing neonatal population and the increasing instances of congenital diseases in newborns. Besides this, various organizations, such as the World Health Organization (WHO), Center for Disease Control (CDC), and Healthy Newborn Network, are educating parents regarding the disorders and their diagnostic procedures. This helps prevent death in babies within the first month of their birth due to lack of skilled care and screening. Furthermore, governments in different countries are also funding programs introducing newborn screening and new treatment options, which is further expected to influence the market growth.

Breakup by Product:

  • Instruments
  • Reagents

Breakup by Technology:

  • Tandem Mass Spectrometry
  • Pulse Oximetry
  • Enzyme Based Assay
  • DNA Assay
  • Electrophoresis
  • Others

Breakup by Test Type:

  • Dry Blood Spot Test
  • CCHD
  • Hearing Screen

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • Agilent Technologies Inc.
  • Baebies Inc.
  • Bio-RAD Laboratories Inc.
  • Chromsystems Instruments & Chemicals GmbH
  • Danaher Corporation
  • Masimo Corporation
  • Medtronic plc
  • Natus Medical Incorporated
  • Perkinelmer Inc.
  • RECIPE Chemicals + Instruments GmbH
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare
  • Waters Corporation.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/newborn-screening-market

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

Email: sales@imarcgroup.com

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal

Related Articles

Back to top button